Analysis of the Tests for New Life Extending Cancer Drugs

Journal Title: Journal of Practical Biochemistry and Biophysics - Year 2017, Vol 2, Issue 2

Abstract

Since many decades basis of research for the detection of the cancer biomarkers is opted by many researcher to identify new drug for cancer. Specific biomarker assessment for the cancer will help in the diagnostic approach for the cancer diagnosis along with the assessment of the progress of the treatment. There are many cases where the association of the cancer with specific biomarker is possible. The example for reference may be the two types of colony stimulating factors, G-CSF and M-CSF. M-CSF promotes the production and activation of Monocytes, and G-CSF stimulates the production of granulocytes from stem cells in the bone marrow. G-CSF and GM-CSF, which are produced by recombinant DNA technology, have been approved by the FDA for use in patients with bone marrow depression, such as cancer patients and patients who receive bone marrow transplants. In these patients it is observed that the bone marrow depression is usually associated with intensive chemotherapy or irradiation, and the use of colony stimulating factors avoids the profound and prolonged neutropenia as seen in controls not receiving these compounds, with a corresponding decrease in morbidity and mortality. On the other hand, administration of G-CSF or GM-CSF is expensive and can be associated with severe side effects. The deployment of the new life extending cancer drugs is needed to be measured for its efficacy. The effect of drugs may be detected through the detection of the low amount of the secondary associated biomarkers of the cancer. The various oncologists have different opinion in use of the detection of the immunogenic biomarkers with cancers.

Authors and Affiliations

Sachin C. Narwadiya

Keywords

Related Articles

Study of Glycosylated Hemoglobin and it’s Relation with Changes in Lipid Profile in Type II Diabetic Patients

Introduction: Patients with type 2 diabetes (T2DM) have an increased prevalence of dyslipidemia, which contributes to their high risk of cardiovascular diseases (CVDs). Hemoglobin A1c (HbA1c) is widely used as an index o...

Handshake of DNA and Protein: A Perspective

DNA is a passive molecule and it can not exist on its own in cellular environment. It exist alongwith proteins and their interaction play a pivotal role in various biological processes such as replication, transcription,...

Single Step Purification of Soybean Isoflavones Employing Silica Gel Adsorption Chromatography

The extraction and purification of isoflavones from defatted soy flour (DSF) are attempted by leaching and adsorption chromatography. The isoflavones were extracted in methanol and processed employing silica gel column c...

Study of Oxidative Stress in Smokers by Estimation of Serum Malondialdehyde Uric Acid and Bilirubin

Background: Study of Malondialdehyde Uric Acid and Bilirubin smokers provides opportunity to explain the correlation between cigarette smoking activity and oxidative stress. Cigarette smoking is the second cause of death...

Ba-ZnO Nanoparticles for Photo-Catalytic Degradation of Methyl Orange

Chemical precipitation method was used to synthesize pure ZnO and Ba-ZnO nanoparticles. The XRD patterns and SEM topography shows that prepared nanoparticles were wurzite structure. The average particle size of 2% Ba-ZnO...

Download PDF file
  • EP ID EP470335
  • DOI -
  • Views 67
  • Downloads 0

How To Cite

Sachin C. Narwadiya (2017). Analysis of the Tests for New Life Extending Cancer Drugs. Journal of Practical Biochemistry and Biophysics, 2(2), 83-87. https://europub.co.uk/articles/-A-470335